Healthcare Bull 3X Direxion (CURE) 147.07 $CURE What To

New Post Public Reply Private Reply Replies (0) Message Board

Mar 31, 2015 at 6:46 PM

Healthcare Bull 3X Direxion (CURE) 147.07 $CURE

What To Expect When The Fed Actually Does Raise Rates
Dirk Leach - at Seeking Alpha - Thu Mar 19, 4:28PM CDT

RYH: 155.22 (-2.05), KXI: 91.57 (-1.30), IYH: 154.32 (-2.24), VDC: 126.99 (-1.00), IPS: 40.21 (-0.64), RXL: 141.39 (-3.75), XLV: 72.50 (-1.28), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), FSTA: 29.56 (-0.22), QQQ: 105.60 (-1.13), DIA: 177.58 (-1.81), FHLC: 35.26 (-0.48), RXD: 12.72 (+0.14), RHS: 107.94 (-0.87), IWM: 124.37 (-0.40), FXG: 44.63 (-0.32), CURE: 147.07 (-6.72), VHT: 135.52 (-1.73), FXH: 67.02 (-0.98)

ETF flows: Out of financials, industrials, tech; into energy, healthcare
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 1:08PM CST

UYG: 145.21 (-1.94), ROM: 153.04 (-3.05), QTEC: 43.43 (-0.45), FXL: 35.76 (-0.34), ERY: 20.24 (+0.47), RGI: 89.89 (-0.50), TECL: 139.07 (-3.90), ERX: 54.83 (-1.37), FXN: 21.10 (-0.19), FXO: 23.62 (-0.09), FNCL: 28.76 (-0.15), FAS: 122.22 (-2.00), FAZ: 12.38 (+0.21), FXH: 67.02 (-0.98), SEF: 17.58 (+0.14), VFH: 49.28 (-0.29), DDG: 26.13 (+0.19), REW: 54.44 (unch), UXI: 118.38 (-1.19), SIJ: 40.21 (+0.54), TECS: 10.56 (+0.23), FIDU: 28.80 (-0.24), FTEC: 32.08 (-0.25), FENY: 22.19 (-0.17), RWW: 48.81 (-0.24), RXD: 12.72 (+0.14), OIH: 33.71 (-0.19), RXL: 141.39 (-3.75), AIRR: 18.99 (-0.04), DUG: 53.33 (+0.89), PXJ: 16.17 (-0.10), VIS: 107.35 (-0.79), XLK: 41.44 (-0.43), FHLC: 35.26 (-0.48), XLI: 55.77 (-0.56), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), CURE: 147.07 (-6.72), VHT: 135.52 (-1.73), XLE: 77.58 (-0.46), IYW: 104.96 (-0.94), FINZ: 22.12 (+1.24), RYH: 155.22 (-2.05), VDE: 109.28 (-0.90), IYJ: 107.87 (-0.77), IYH: 154.32 (-2.24), IGM: 103.13 (-0.77), DIG: 50.65 (-0.88), FINU: 83.86 (-0.79), IYG: 89.49 (-0.34), RYT: 91.90 (-0.69), IYF: 89.05 (-0.48), IYE: 43.60 (-0.35), XLV: 72.50 (-1.28), FXR: 31.16 (-0.18), MTK: 100.34 (-0.67), VGT: 106.52 (-0.53)

How To Buy And Hold Leveraged ETFs: The Top 7 Outperforming 3x ETFs Over The Past Year
Force Majeure - at Seeking Alpha - Tue Jan 27, 1:53PM CST

USO: 16.84 (-0.39), UUPT: 29.72 (-0.06), TQQQ: 102.99 (-3.29), UUP: 25.90 (+0.04), TLT: 130.69 (+0.28), XRT: 101.04 (-0.54), XLV: 72.50 (-1.28), QQQ: 105.60 (-1.13), DNO: 61.89 (+1.41), RETL: 128.91 (-0.66), DRN: 88.00 (-2.29), VNQ: 84.31 (-0.75), DWTI: 133.30 (+8.40), CURE: 147.07 (-6.72), TMF: 94.96 (+0.62)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 31.04 (-0.49), RXL: 141.39 (-3.75), XBI: 225.50 (+1.13), IHE: 172.42 (-2.24), IHF: 133.06 (-1.07), PPH: 70.24 (-1.05), XHE: 95.50 (-0.45), BBC: 32.83 (-0.63), PTH: 60.60 (-1.08), BBH: 129.58 (-3.38), FHLC: 35.26 (-0.48), IHI: 120.29 (-0.98), CURE: 147.07 (-6.72), FXH: 67.02 (-0.98), VHT: 135.52 (-1.73), RYH: 155.22 (-2.05), PBE: 55.14 (-1.11), IYH: 154.32 (-2.24), FBT: 118.23 (-2.67), XHS: 124.42 (-0.51), XPH: 123.52 (-1.47), XLV: 72.50 (-1.28), SBIO: 29.87 (-0.25), PSCH: 68.93 (-0.19), PJP: 76.40 (-1.07), RXD: 12.72 (+0.14)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 31.04 (-0.49), RXL: 141.39 (-3.75), XBI: 225.50 (+1.13), IBB: 343.43 (-7.89), IHE: 172.42 (-2.24), IHF: 133.06 (-1.07), BBC: 32.83 (-0.63), PPH: 70.24 (-1.05), XHE: 95.50 (-0.45), PTH: 60.60 (-1.08), BBH: 129.58 (-3.38), FHLC: 35.26 (-0.48), IHI: 120.29 (-0.98), CURE: 147.07 (-6.72), FXH: 67.02 (-0.98), VHT: 135.52 (-1.73), RYH: 155.22 (-2.05), PBE: 55.14 (-1.11), IYH: 154.32 (-2.24), FBT: 118.23 (-2.67), XHS: 124.42 (-0.51), XPH: 123.52 (-1.47), XLV: 72.50 (-1.28), SBIO: 29.87 (-0.25), PSCH: 68.93 (-0.19), PJP: 76.40 (-1.07), RXD: 12.72 (+0.14)

Major Shift In Primary Data Sets Reveals Rare Opportunity
Craig Mauk - at Seeking Alpha - Thu Dec 04, 9:39AM CST

SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), DIA: 177.58 (-1.81), SPXL: 88.44 (-2.36), CURE: 147.07 (-6.72), UUP: 25.90 (+0.04)

Healthy Returns From The Healthcare Sector
Sy Harding - at Seeking Alpha - Mon Nov 10, 8:09AM CST
Healthcare stocks, along with the stocks of food and drink companies are often recommended as defensive holdings for bear markets, on the premise that no matter what happens people will always have to eat, drink, and take their medicine. The other...
RYH: 155.22 (-2.05), IYH: 154.32 (-2.24), RXL: 141.39 (-3.75), FHLC: 35.26 (-0.48), RXD: 12.72 (+0.14), CURE: 147.07 (-6.72), FXH: 67.02 (-0.98), VHT: 135.52 (-1.73), XLV: 72.50 (-1.28)

Top 10 Momentum ETFs For October 27, 2014
CapitalCube - Seeking Alpha - Tue Oct 28, 12:11PM CDT
By Veibha Subramaniam The data was compiled using CapitalCube's ETF Screener Utilities and Health care were the biggest gainers Momentum ETFs have been identified as those ETFs that are trading at a price discount to their 52 week high...
IYH: 154.32 (-2.24), VDC: 126.99 (-1.00), RXL: 141.39 (-3.75), DTO: 111.00 (+3.98), UXI: 118.38 (-1.19), UPW: 94.89 (+0.04), XLU: 44.43 (+0.01), TQQQ: 102.99 (-3.29), SCO: 87.14 (+3.68), QLD: 142.55 (-3.35), IHE: 172.42 (-2.24), XLP: 48.74 (-0.46), FBG: 57.95 (-0.74), UGE: 99.57 (unch), IDU: 111.76 (-0.05), SPHD: 32.89 (-0.15), FHLC: 35.26 (-0.48), VPU: 96.88 (+0.04), RHS: 107.94 (-0.87), CURE: 147.07 (-6.72)

Top 10 ETF Gainers And Losers For October 17, 2014
CapitalCube - Seeking Alpha - Sun Oct 19, 8:29AM CDT
By Veibha Subramaniam Top 10 ETF gainers with assets of more than $25 million as of Oct 17, 2014. (Non-Leveraged) The data was compiled using CapitalCube's ETF Screener Symbol Company 1 Day Price Return (%) Average Daily Volume...
JO: 23.25 (-0.10), VXX: 25.63 (+0.67), GREK: 11.02 (+0.05), XOP: 51.66 (+2.15), UVXY: 15.05 (+0.74), FIEU: 113.58 (-3.82), VXZ: 12.57 (+0.11), SDOW: 19.71 (+0.59), XIV: 34.64 (-0.89), SPXU: 35.99 (+0.92), EPV: 56.34 (+1.63), IDX: 24.65 (+0.01), SPXS: 19.43 (+0.51), GLDX: 9.64 (-0.04), SQQQ: 26.76 (+0.84), JNUG: 16.96 (-0.14), SGDM: 16.78 (-0.15), DZK: 65.81 (-3.26), GXF: 23.81 (-0.34), DUST: 19.20 (+0.69), GDX: 18.24 (-0.23), CURE: 147.07 (-6.72), JDST: 12.21 (+0.10), TVIX: 1.70 (+0.08), VIXM: 61.09 (+0.58), CFGE: 11.00 (-0.08), FEEU: 109.50 (-3.73), UXI: 118.38 (-1.19), SIL: 8.41 (-0.11), NUGT: 9.42 (-0.37), SVXY: 68.04 (-1.70), HEWG: 28.54 (-0.35), BXUC: 299.86 (unch), RUSL: 21.59 (-0.86), BRF: 16.28 (+0.13), EIDO: 27.75 (+0.13), EWZ: 31.37 (+0.28), UDOW: 139.66 (-4.56), VIXY: 17.01 (+0.43), ENOR: 22.68 (-0.25)

Daily Healthcare Bull 3x Shares (CURE)
Trading Central - Wed Jun 04, 8:42AM CDT
The ETF is losing upward momentum, we are cautious now and we prefer to take profit right now ($84.95) on the long position opened on May 22th. Performance: +4.07%.
CURE: 147.07 (-6.72)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating Battery Compliance for AI Data Centers

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Special Needs Group Partners with MAST to Enhance Accessibility

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Quark Baby's Milk Warmer Debut at Vancouver & Dubai

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

CMC Declares Dividend Amid Complex Outlook

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...